Open AccessConstruction of a New Tumor Immunity-Related Signature to Assess and Classify the Prognostic Risk of Colorectal Cancer
Author(s) -
XiaoCheng Wu,
Tianxing Yang,
Liping Qian,
John A. Stankovic,
Hui Yang
Publication year - 2021
Publication title -
international journal of general medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.722
H-Index - 36
ISSN - 1178-7074
DOI - 10.2147/ijgm.s325511
Subject(s) - nomogram , medicine , colorectal cancer , oncology , proportional hazards model , immunotherapy , gene signature , immune system , gene , kegg , cancer , bioinformatics , computational biology , immunology , gene expression , transcriptome , biology , genetics
Although immunotherapy and checkpoint inhibitors contribute to the treatment of colorectal cancer (CRC), few patients can benefit from these treatments. Therefore, our goal was to develop a marker based on immune-related genes to predict the prognosis of patients with CRC to guide treatment strategies.